Explore

TheStreet TheStreet
Billionaire Stanley Druckenmiller gets sharp response from Scott Bessent

Billionaire Stanley Druckenmiller gets sharp response from Scott Bessent

Stanley Druckenmiller sounds alarm on Treasury’s bond strategy, but his former protégé Scott Bessent says the billionaire may have lost money on the trade.
Rapid Read Rapid Read
Aging Clocks Show Promise for Longevity Interventions but Face Reliability Challenges

Aging Clocks Show Promise for Longevity Interventions but Face Reliability Challenges

Aging clocks, developed using machine learning techniques on biological data, are designed to predict age-related conditions and mortality risk. These clocks utilize various data types, including omics data, clinical chemistry results from blood tests, and imaging data. When applied to individuals, a higher predicted age compared to chronological age often correlates with increased mortality risk and the presence of age-related conditions. The primary goal for these aging clocks is to provide a rapid assessment tool for novel longevity interventions, potentially eliminating the need for lengthy, decade-spanning clinical trials. However, a significant challenge remains: ensuring the reliability of these clocks in assessing the efficacy of new interventions. There is currently no direct, well-mapped connection between the data used to derive these clocks and the underlying mechanisms of aging, making it difficult to predict whether a given clock will accurately estimate the effects of a treatment without ext...
Rapid Read Rapid Read
Cleveland Clinic Unveils Two New Research Buildings, Marking Largest Investment in its History

Cleveland Clinic Unveils Two New Research Buildings, Marking Largest Investment in its History

Cleveland Clinic has officially opened two new state-of-the-art research buildings on its Main Campus, representing the largest research investment in the organization's over 100-year history. These new facilities, totaling 300,000 square feet, are located at E. 100th Street and Cedar Avenue. The expansion significantly boosts Cleveland Clinic's research and innovation infrastructure, providing space for more than 700 employees and nearly 30 laboratories and core service areas. The buildings are designed to support high-level scientific work, including computational research, and increase the capacity for scientific discovery. This project was supported by investments from the State of Ohio and JobsOhio, as part of the Cleveland Innovation District initiative, which aims to foster transformative research, education, job creation, and commercialization opportunities in Ohio. Cleveland Clinic CEO and President Tom Mihaljevic, M.D., emphasized that these facilities will accelerate scientific discovery and str...
Trendline Trendline
ProFound Therapeutics Secures $35 Million Partnership with Gates Foundation to Combat Preeclampsia

ProFound Therapeutics Secures $35 Million Partnership with Gates Foundation to Combat Preeclampsia

ProFound Therapeutics Secures $35 Million Partnership with Gates Foundation to Combat Preeclampsia
Trendline Trendline
Isomorphic Labs Secures $2.1 Billion Funding to Advance AI Drug Design

Isomorphic Labs Secures $2.1 Billion Funding to Advance AI Drug Design

Isomorphic Labs Secures $2.1 Billion Funding to Advance AI Drug Design
Trendline Trendline
Mitch Joel Questions AI's Role in Human Work, Emphasizing Value Beyond Efficiency

Mitch Joel Questions AI's Role in Human Work, Emphasizing Value Beyond Efficiency

Mitch Joel Questions AI's Role in Human Work, Emphasizing Value Beyond Efficiency
Rapid Read Rapid Read
CRISPR-Based Gene Therapy Shows Promise in Sustaining Lower Lipid Levels for a Year

CRISPR-Based Gene Therapy Shows Promise in Sustaining Lower Lipid Levels for a Year

Researchers have reported promising results from a small study involving a one-time CRISPR-based gene therapy shot that helped individuals with elevated cholesterol and triglyceride levels maintain significantly lower lipid levels for at least a year. Mel Mann, a patient advocate, highlighted this development, noting that the therapy represents a 'different model' compared to traditional treatments. The study, though small and involving severe cases, demonstrated that the highest dose of the CRISPR shot reduced LDL cholesterol and triglycerides by approximately half, with the effects sustained over the year. This suggests a potential for a durable therapeutic intervention for lipid management through gene editing.
Trendline Trendline
AI-Driven Platforms Automate Startup Discovery and Market Intelligence for U.S. Businesses

AI-Driven Platforms Automate Startup Discovery and Market Intelligence for U.S. Businesses

AI-Driven Platforms Automate Startup Discovery and Market Intelligence for U.S. Businesses
Trendline Trendline
GenAIz Launches AIHQ to Enhance GxP Compliance in Life Sciences, Reducing Costs and Risks

GenAIz Launches AIHQ to Enhance GxP Compliance in Life Sciences, Reducing Costs and Risks

GenAIz Launches AIHQ to Enhance GxP Compliance in Life Sciences, Reducing Costs and Risks
Trendline Trendline
Hong Kong Ranks Fifth Globally in Start-up Potential, Leads Asia

Hong Kong Ranks Fifth Globally in Start-up Potential, Leads Asia

Hong Kong Ranks Fifth Globally in Start-up Potential, Leads Asia
Rapid Read Rapid Read
Infectious Disease Experts Re-evaluate Long-Held Antibiotic Advice, Emphasizing Shorter Courses

Infectious Disease Experts Re-evaluate Long-Held Antibiotic Advice, Emphasizing Shorter Courses

Infectious disease experts are challenging the long-standing advice for patients to always 'finish the course' of antibiotics. This traditional guidance, promoted by organizations like the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO), was based on the misconception that stopping antibiotics early would lead to resistant bacteria. However, current research indicates that this is not the primary driver of antimicrobial resistance (AMR). Instead, antibiotic exposure itself creates selective pressure for resistant bacteria to emerge. The focus is now shifting towards prescribing the shortest effective course of antibiotics to treat an infection successfully, while minimizing unnecessary exposure. This approach aims to reduce the disruption to the body's microbiome, which can give resistant bacteria a survival advantage. Studies have shown that for various infections, including bladder infections, pneumonia, and bloodstream infections, shorter courses can be as effect...
Trendline Trendline
Insight Partners Leads $26 Million Series B Funding for Gridsight to Expand U.S. Market Presence

Insight Partners Leads $26 Million Series B Funding for Gridsight to Expand U.S. Market Presence

Insight Partners Leads $26 Million Series B Funding for Gridsight to Expand U.S. Market Presence